RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Antonei Benjamin Csoka to Humans

This is a "connection" page, showing publications Antonei Benjamin Csoka has written about Humans.
Connection Strength

0.458
  1. Csoka AB, El Kouhen N, Bennani S, Getachew B, Aschner M, Tizabi Y. Roles of Epigenetics and Glial Cells in Drug-Induced Autism Spectrum Disorder. Biomolecules. 2024 Apr 03; 14(4).
    View in: PubMed
    Score: 0.045
  2. Alhazzaa RA, McKinley RE, Getachew B, Tizabi Y, Heinbockel T, Csoka AB. Epigenetic Changes Induced by High Glucose in Human Pancreatic Beta Cells. J Diabetes Res. 2023; 2023:9947294.
    View in: PubMed
    Score: 0.041
  3. Heinbockel T, Csoka AB. Epigenetic Effects of Drugs of Abuse. Int J Environ Res Public Health. 2018 09 25; 15(10).
    View in: PubMed
    Score: 0.031
  4. Zhavoronkov A, Izumchenko E, Kanherkar RR, Teka M, Cantor C, Manaye K, Sidransky D, West MD, Makarev E, Csoka AB. Pro-fibrotic pathway activation in trabecular meshwork and lamina cribrosa is the main driving force of glaucoma. Cell Cycle. 2016 06 17; 15(12):1643-52.
    View in: PubMed
    Score: 0.026
  5. Csoka AB. Innovation in medicine: Ignaz the reviled and Egas the regaled. Med Health Care Philos. 2016 Jun; 19(2):163-8.
    View in: PubMed
    Score: 0.026
  6. Csoka AB, Stern R. Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology. 2013 Apr; 23(4):398-411.
    View in: PubMed
    Score: 0.021
  7. Csoka AB, Szyf M. Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology. Med Hypotheses. 2009 Nov; 73(5):770-80.
    View in: PubMed
    Score: 0.016
  8. Csoka AB, Csoka A, Bahrick A, Mehtonen OP. Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors. J Sex Med. 2008 Jan; 5(1):227-33.
    View in: PubMed
    Score: 0.015
  9. Csoka AB, Shipko S. Persistent sexual side effects after SSRI discontinuation. Psychother Psychosom. 2006; 75(3):187-8.
    View in: PubMed
    Score: 0.013
  10. Constantinescu D, Gray HL, Sammak PJ, Schatten GP, Csoka AB. Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells. 2006 Jan; 24(1):177-85.
    View in: PubMed
    Score: 0.012
  11. Csoka AB, English SB, Simkevich CP, Ginzinger DG, Butte AJ, Schatten GP, Rothman FG, Sedivy JM. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell. 2004 Aug; 3(4):235-43.
    View in: PubMed
    Score: 0.011
  12. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet. 2004 Apr; 41(4):304-8.
    View in: PubMed
    Score: 0.011
  13. Bhatia-Dey N, Csoka AB, Heinbockel T. Chemosensory Ability and Sensitivity in Health and Disease: Epigenetic Regulation and COVID-19. Int J Mol Sci. 2023 Feb 20; 24(4).
    View in: PubMed
    Score: 0.010
  14. Getachew B, Csoka AB, Copeland RL, Manaye KF, Tizabi Y. Dihydromyricetin Protects Against Salsolinol-Induced Toxicity in Dopaminergic Cell Line: Implication for Parkinson's Disease. Neurotox Res. 2023 Apr; 41(2):141-148.
    View in: PubMed
    Score: 0.010
  15. Getachew B, Csoka AB, Tizabi Y. Dihydromyricetin Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line: Role of GABAA Receptor. Neurotox Res. 2022 Jun; 40(3):892-899.
    View in: PubMed
    Score: 0.010
  16. Healy D, Bahrick A, Bak M, Barbato A, Calabr? RS, Chubak BM, Cosci F, Csoka AB, D'Avanzo B, Diviccaro S, Giatti S, Goldstein I, Graf H, Hellstrom WJG, Irwig MS, Jannini EA, Janssen PKC, Khera M, Kumar MT, Le Noury J, Lew-Starowicz M, Linden DEJ, L?ning C, Mangin D, Melcangi RC, Rodr?guez OWMAAS, Panicker JN, Patacchini A, Pearlman AM, Pukall CF, Raj S, Reisman Y, Rubin RS, Schreiber R, Shipko S, Va?eckov? B, Waraich A. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022; 33(1):65-76.
    View in: PubMed
    Score: 0.010
  17. Csoka AB, Frost GI, Stern R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001 Dec; 20(8):499-508.
    View in: PubMed
    Score: 0.010
  18. Getachew B, Csoka AB, Garden AR, Copeland RL, Tizabi Y. Sodium Butyrate Protects Against Ethanol-Induced Toxicity in SH-SY5Y Cell Line. Neurotox Res. 2021 Dec; 39(6):2186-2193.
    View in: PubMed
    Score: 0.009
  19. Getachew B, Csoka AB, Bhatti A, Copeland RL, Tizabi Y. Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease. Neurotox Res. 2020 Oct; 38(3):596-602.
    View in: PubMed
    Score: 0.009
  20. Cs?ka AB, Scherer SW, Stern R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics. 1999 Sep 15; 60(3):356-61.
    View in: PubMed
    Score: 0.008
  21. Tizabi Y, Getachew B, Csoka AB, Manaye KF, Copeland RL. Novel targets for parkinsonism-depression comorbidity. Prog Mol Biol Transl Sci. 2019; 167:1-24.
    View in: PubMed
    Score: 0.008
  22. Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y. Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol. 2018 12 22; 18(1):222.
    View in: PubMed
    Score: 0.008
  23. Getachew B, Csoka AB, Aschner M, Tizabi Y. Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease. Neurochem Int. 2019 03; 124:19-24.
    View in: PubMed
    Score: 0.008
  24. Getachew B, Hudson T, Heinbockel T, Csoka AB, Tizabi Y. Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3. Neurotox Res. 2018 Oct; 34(3):757-762.
    View in: PubMed
    Score: 0.007
  25. Cs?ka AB, Frost GI, Heng HH, Scherer SW, Mohapatra G, Stern R, Cs?ka TB. The hyaluronidase gene HYAL1 maps to chromosome 3p21.2-p21.3 in human and 9F1-F2 in mouse, a conserved candidate tumor suppressor locus. Genomics. 1998 Feb 15; 48(1):63-70.
    View in: PubMed
    Score: 0.007
  26. Tizabi Y, Getachew B, Ferguson CL, Csoka AB, Thompson KM, Gomez-Paz A, Ruda-Kucerova J, Taylor RE. Low Vs. High Alcohol: Central Benefits Vs. Detriments. Neurotox Res. 2018 Nov; 34(4):860-869.
    View in: PubMed
    Score: 0.007
  27. Cs?ka AB, Frost GI, Wong T, Stern R, Cs?ka TB. Purification and microsequencing of hyaluronidase isozymes from human urine. FEBS Lett. 1997 Nov 17; 417(3):307-10.
    View in: PubMed
    Score: 0.007
  28. Manavalan S, Getachew B, Manaye KF, Khundmiri SJ, Csoka AB, McKinley R, Tamas A, Reglodi D, Tizabi Y. PACAP Protects Against Ethanol and Nicotine Toxicity in SH-SY5Y Cells: Implications for Drinking-Smoking Co-morbidity. Neurotox Res. 2017 Jul; 32(1):8-13.
    View in: PubMed
    Score: 0.007
  29. Cs?ka TB, Frost GI, Stern R, Cs?ka AB. Hyaluronidases in tissue invasion. Invasion Metastasis. 1997; 17(6):297-311.
    View in: PubMed
    Score: 0.007
  30. Ben-Sheetrit J, Aizenberg D, Csoka AB, Weizman A, Hermesh H. Post-SSRI Sexual Dysfunction: Clinical Characterization and Preliminary Assessment of Contributory Factors and Dose-Response Relationship. J Clin Psychopharmacol. 2015 Jun; 35(3):273-8.
    View in: PubMed
    Score: 0.006
  31. Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A, Zhavoronkov A. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging (Albany NY). 2015 Jan; 7(1):26-37.
    View in: PubMed
    Score: 0.006
  32. Steinhauser G, Adlassnig W, Risch JA, Anderlini S, Arguriou P, Armendariz AZ, Bains W, Baker C, Barnes M, Barnett J, Baumgartner M, Baumgartner T, Bendall CA, Bender YS, Bichler M, Biermann T, Bini R, Blanco E, Bleau J, Brink A, Brown D, Burghuber C, Calne R, Carter B, Casta?o C, Celec P, Celis ME, Clarke N, Cockrell D, Collins D, Coogan B, Craig J, Crilly C, Crowe D, Csoka AB, Darwich C, Del Kebos T, Derinaldi M, Dlamini B, Drewa T, Dwyer M, Eder F, de Palma RE, Esmay D, R?tt CE, Exley C, Falkov R, Farber CI, Fearn W, Felsmann S, Flensmark J, Fletcher AK, Foster M, Fountoulakis KN, Fouratt J, Blanca JG, Sotelo MG, Gittler F, Gittler G, Gomez J, Gomez JF, Polar MG, Gonzalez J, G?sselsberger C, Habermacher L, Hajek M, Hakala F, Haliburton MS, Hankins JR, Hart J, Hasslberger S, Hennessey D, Herrmann A, Hersee M, Howard C, Humphries S, Isharc L, Ivanovski P, Jenuth S, Jerndal J, Johnson C, Keleta Y, Kenny A, Kidd B, Kohle F, Kolahi J, Koller-Peroutka M, Kostova L, Kumar A, Kurosawa A, Lance T, Lechermann M, Lendl B, Leuchters M, Lewis E, Lieb E, Lloyd G, Losek A, Lu Y, Maestracci S, Mangan D, Mares AW, Barnett JM, McClain V, McNair JS, Michael T, Miller L, Monzani P, Moran B, Morris M, M??mer G, Mountain J, Phuthe OM, Mu?oz M, Nakken S, Wambui AN, Neunteufl B, Nikolic D, Oberoi DV, Obmode G, Ogar L, Ohara J, Rybine NO, Owen B, Owen KW, Parikh R, Pearce NJ, Pemmer B, Piper C, Prince I, Reid T, Rindermann H, Risch S, Robbins J, Roberts S, Romero A, Rothe MT, Ruiz S, Sacher J, Sackl W, Salletmaier M, Sanand J, Sauerzopf C, Schwarzgruber T, Scott D, Seegers L, Seppi D, Shields K, Siller-Matula J, Singh B, Sithole S, Six F, Skoyles JR, Slofstra J, Sole DA, Sommer WF, Sonko M, Starr-Casanova CJ, Steakley ME, Steinhauser W, Steinhoff K, Sterba JH, Steppan M, Stindl R, Stokely J, Stokely K, St-Pierre G, Stratford J, Streli C, Stryg C, Sullivan M, Summhammer J, Tadesse A, Tavares D, Thompson L, Tomlinson A, Tozer J, Trevisanato SI, Trimmel M, Turner N, Vahur P, van der Byl J, van der Maas T, Varela L, Vega CA, Vermaak S, Villasenor A, Vogel M, von Wintzigerode G, Wagner C, Weinberger M, Weinberger P, Wilson N, Wolfe JF, Woodley MA, Young I, Zuraw G, Zwiren N. Peer review versus editorial review and their role in innovative science. Theor Med Bioeth. 2012 Oct; 33(5):359-76.
    View in: PubMed
    Score: 0.005
  33. Constantinescu D, Csoka AB, Navara CS, Schatten GP. Defective DSB repair correlates with abnormal nuclear morphology and is improved with FTI treatment in Hutchinson-Gilford progeria syndrome fibroblasts. Exp Cell Res. 2010 Oct 15; 316(17):2747-59.
    View in: PubMed
    Score: 0.004
  34. Martin DC, Atmuri V, Hemming RJ, Farley J, Mort JS, Byers S, Hombach-Klonisch S, Csoka AB, Stern R, Triggs-Raine BL. A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis. Hum Mol Genet. 2008 Jul 01; 17(13):1904-15.
    View in: PubMed
    Score: 0.004
  35. Gordon LB, Harten IA, Calabro A, Sugumaran G, Csoka AB, Brown WT, Hascall V, Toole BP. Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome. Hum Genet. 2003 Jul; 113(2):178-87.
    View in: PubMed
    Score: 0.003
  36. Eriksson M, Brown WT, Gordon LB, Glynn MW, Singer J, Scott L, Erdos MR, Robbins CM, Moses TY, Berglund P, Dutra A, Pak E, Durkin S, Csoka AB, Boehnke M, Glover TW, Collins FS. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003 May 15; 423(6937):293-8.
    View in: PubMed
    Score: 0.003
  37. Shuster S, Frost GI, Csoka AB, Formby B, Stern R. Hyaluronidase reduces human breast cancer xenografts in SCID mice. Int J Cancer. 2002 Nov 10; 102(2):192-7.
    View in: PubMed
    Score: 0.003
  38. Nicoll SB, Barak O, Cs?ka AB, Bhatnagar RS, Stern R. Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem Biophys Res Commun. 2002 Apr 12; 292(4):819-25.
    View in: PubMed
    Score: 0.002
  39. Nawy SS, Cs?ka AB, Mio K, Stern R. Hyaluronidase activity and hyaluronidase inhibitors. Assay using a microtiter-based system. Methods Mol Biol. 2001; 171:383-9.
    View in: PubMed
    Score: 0.002
  40. Mio K, Cs?ka AB, Nawy SS, Stern R. Detecting hyaluronidase and hyaluronidase inhibitors. Hyaluronan-substrate gel and -inverse substrate gel techniques. Methods Mol Biol. 2001; 171:391-7.
    View in: PubMed
    Score: 0.002
  41. Frost GI, Mohapatra G, Wong TM, Cs?ka AB, Gray JW, Stern R. HYAL1LUCA-1, a candidate tumor suppressor gene on chromosome 3p21.3, is inactivated in head and neck squamous cell carcinomas by aberrant splicing of pre-mRNA. Oncogene. 2000 Feb 17; 19(7):870-7.
    View in: PubMed
    Score: 0.002
  42. Laugier JP, Shuster S, Rosdy M, Cs?ka AB, Stern R, Maibach HI. Topical hyaluronidase decreases hyaluronic acid and CD44 in human skin and in reconstituted human epidermis: evidence that hyaluronidase can permeate the stratum corneum. Br J Dermatol. 2000 Feb; 142(2):226-33.
    View in: PubMed
    Score: 0.002
  43. Stair-Nawy S, Cs?ka AB, Stern R. Hyaluronidase expression in human skin fibroblasts. Biochem Biophys Res Commun. 1999 Dec 09; 266(1):268-73.
    View in: PubMed
    Score: 0.002
  44. Frost GI, Cs?ka AB, Wong T, Stern R, Cs?ka TB. Purification, cloning, and expression of human plasma hyaluronidase. Biochem Biophys Res Commun. 1997 Jul 09; 236(1):10-5.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support